US Patent 11167035 Insulin compositions and method of making a composition
Patent 11167035 was granted and assigned to Novo Nordisk on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+276 characters)
Article
Patent abstract
The invention is related to insulin compositions with a high content of zinc atoms per six molecules of acylated insulin. The insulin is an acylated insulin and may be mixed with a further insulin analogue such as the rapid acting insulin Asp B28 human insulin.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Anne Plum0
Frantisek Hubalek0
Helle Birk Olsen0
Ib Jonassen0
Svend Havelund0
Thomas Hoeg-Jensen0
Ulla Ribel-Madsen0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111670350
Date of Patent
November 9, 2021
0Patent Application Number
201407160
Date Filed
July 16, 2014
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Nov, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11167035 Insulin compositions and method of making a composition
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11167035
Date of patent
November 9, 2021
Patent application number
20140716
Date Filed
July 16, 2014
Patent primary examiner
Find more entities like US Patent 11167035 Insulin compositions and method of making a composition
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
